News

Siemens, MES contract, William Osler Health System, Ontario, Canada

Canadian hospital William Osler Health System (Osler), based in Ontario, has awarded Siemens Healthcare a Managed Equipment Services (MES) contract worth €110 million (C$154 million)....

InspireMD, CGuard, PARADIGM study, EuroPCR 2015, Musialek

InspireMD Inc. announced that its CGuard embolic prevention system reported positive results in the PARADIGM study at the EuroPCR conference, May 22 in Paris. The study was lead by principle...

Medtronic, CoreValve Evolut R, FDA approval, TAVR, recapturable

Medtronic plc announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the recapturable, self-expanding CoreValve Evolut R System. The first-and-only recapturable and...

cangrelor, Kangreal, FDA approval, The Medicines Company, antiplatelet agent

The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy to percutaneous coronary...

Edwards, Sapien 3, FDA approval, transcatheter heart valve

Edwards Lifesciences Corp. announced U.S. Food and Drug Administration (FDA) approval of the Edwards Sapien 3 valve with the Commander Delivery System for the treatment of high-risk patients...

Stentys, Xposition S, CE Mark, EuroPCR

Stentys announced in April that it received CE Marking for its new Self-Apposing stent system ahead of plan. The designation will allow the company to market the new products in Europe and in...

IMRIS Inc. received a letter May 26 from the NASDAQ Stock Market stating that it would be delisted and trading suspended on June 4. IMRIS said this was in accordance with Listing Rules 5101, 5110(...

Karam Moon, M.D., winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, presented his research, The Myth of Restenosis after Carotid Angioplasy and Stenting, at the American...

Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures...

STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI

Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 

Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use

C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix drug-coated balloon (DCB) under the Medicare hospital...

ECRI Institute, review, Impella RP, Abiomed

ECRI Institute recently reviewed published data on Abiomed’s Impella RP (Right Percutaneous) transcatheter ventricular assist device (VAD). The institute said the device provides immediate...

Cardiac computed tomography angiography (CCTA) is known to have excellent anatomical imaging, but has lacked the ability for functional assessments, requiring chest pain patients with intermediate...

Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove blood clots from a patient with a cold leg using the Aspire mechanical...

Biotronik, Pulsar-18, Michael Lichtenberg, study

Biotronik announced the publication of promising clinical results regarding its Pulsar-18 stent platform. Adding to the similarly encouraging data collected in the earlier 4EVER and PEACE...

Cordis Corp., Cordis Crossing Portfolio, Elitecross, Outback Elite, CTO

Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe and Japan. This expands the Cordis...

Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results

AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose aspirin, at the American College of...

Penumbra, ACE64, aspiration thrombectomy, acute ischemic stroke, FDA

Penumbra Inc. announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the U.S. Food and Drug Administration for the revascularization of large...

Fantom, REVA Medical, FANTOM II trial, ACC

REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of its Fantom sirolimus-eluting bioresorbable scaffold in March. The scaffold, made from REVA's...

Medtronic, Euphora SC balloon, CE Mark, Europe, Richard Edwards

Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries that recognize the CE (Conformité Européene) mark in February. The first patient case with...